ArticleThe protein journal2024

Engineering Human Pancreatic RNase 1 as an Immunotherapeutic Agent for Cancer Therapy Through Computational and Experimental Studies.

Mohammadreza Nassiri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.